Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Assam govt to tweak investment policies to attract pharma industry

      Assam govt to tweak investment policies to attract pharma industry

      Ruby Khatun Khatun5 Feb 2018 10:45 AM IST
      Guwahati: Assam government on Sunday said it is ready to tweak its investment policies to attract the pharmaceutical sector for setting up units in...
      Mylan launches generic Sustiva tablets in US for HIV treatment

      Mylan launches generic Sustiva tablets in US for HIV treatment

      Ruby Khatun Khatun5 Feb 2018 10:00 AM IST
      HERTFORDSHIRE, England, and PITTSBURGH: Mylan NV announced the US launch of Efavirenz Tablets USP, 600 mg, the first generic version of Bristol-Myers...
      Siemens Healthineers receives FDA clearance for Epoc BUN, TC02 tests

      Siemens Healthineers receives FDA clearance for Epoc BUN, TC02 tests

      Ruby Khatun Khatun5 Feb 2018 9:45 AM IST
      MALVERN, Pa.: Siemens Healthineers announced it has received 510(k) clearance from the U.S. Food and Drug Administration for its Blood Urea Nitrogen...
      AstraZeneca profits down due to loss of key patents in US

      AstraZeneca profits down due to loss of key patents in US

      Ruby Khatun Khatun5 Feb 2018 9:30 AM IST
      London: AstraZeneca said that net profits slid in 2017, as it continued to be hit by the loss of exclusivity on key blockbuster drugs in the United...
      Budget 2018: Domestic medical devices manufacturers cry foul

      Budget 2018: Domestic medical devices manufacturers cry foul

      Ruby Khatun Khatun4 Feb 2018 1:58 PM IST
      Mumbai: Budget 2018 came as a rude shock to domestic medical device manufacturers as the finance ministry decided that while it will raised the...
      Lupin gets USFDA nod to market its skin conditions cream

      Lupin gets USFDA nod to market its skin conditions cream

      Ruby Khatun Khatun4 Feb 2018 10:45 AM IST
      New Delhi: Drug firm Lupin said it has received the final nod from the US health regulator to market its Clobetasol Propionate cream used for the...
      DRL launches generic Tetrabenazine tablets in US

      DRL launches generic Tetrabenazine tablets in US

      Ruby Khatun Khatun4 Feb 2018 10:30 AM IST
      New Delhi: Dr Reddy's Laboratories (DRL) said it has launched in the US market generic Tetrabenazine tablets used for the treatment of involuntary...
      Trademark infringement: Dabur drags Marico to court

      Trademark infringement: Dabur drags Marico to court

      Ruby Khatun Khatun4 Feb 2018 10:19 AM IST
      New Delhi: Trouble seems mounting for the Mumbai based Marico, as the rival Dabur has filed a case against the company in Delhi High Court for...
      Suven gets product patents from Aripo and South Korea

      Suven gets product patents from Aripo and South Korea

      Ruby Khatun Khatun4 Feb 2018 10:15 AM IST
      New Delhi: Suven Life Sciences has secured a product patent each from African Regional Intellectual Property Organisation (Aripo) and South Korea...
      Intec Pharma names R Michael Gendreau as chief medical officer

      Intec Pharma names R Michael Gendreau as chief medical officer

      Ruby Khatun Khatun4 Feb 2018 10:00 AM IST
      JERUSALEM: Intec Pharma Ltd., a clinical-stage biopharmaceutical company focused on developing pharmaceutical therapies based on its proprietary...
      Biotech mergers and acquisitions explodes with 27.5 billion dollars of January deals

      Biotech mergers and acquisitions explodes with 27.5 billion dollars of January deals

      Ruby Khatun Khatun4 Feb 2018 9:45 AM IST
      LONDON: Biotech deal-making is the hottest in more than a decade with $27.5 billion of transactions agreed this month and bankers reporting an...
      Novo Nordisk CEO welcomes Amazon, Berkshire, JPMorgan pharma company

      Novo Nordisk CEO welcomes Amazon, Berkshire, JPMorgan pharma company

      Ruby Khatun Khatun4 Feb 2018 9:30 AM IST
      COPENHAGEN: Novo Nordisk's chief executive welcomes that Amazon.com Inc, Berkshire Hathaway Inc, and JPMorgan Chase & Co, has established a new...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok